These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

753 related items for PubMed ID: 17356391

  • 1. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
    Mitsiakos G, Papaioannou G, Giougi E, Karagianni P, Garipidou V, Nikolaidis N.
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
    [Abstract] [Full Text] [Related]

  • 2. Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbances.
    Gkiougki E, Mitsiakos G, Chatziioannidis E, Papadakis E, Nikolaidis N.
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):221-6. PubMed ID: 23511491
    [Abstract] [Full Text] [Related]

  • 3. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM, Easley RB, Tobias JD.
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [Abstract] [Full Text] [Related]

  • 4. Recombinant factor VIIa: unregulated continuous use in patients with bleeding and coagulopathy does not alter mortality and outcome.
    Ganguly S, Spengel K, Tilzer LL, O'neal B, Simpson SQ.
    Clin Lab Haematol; 2006 Oct; 28(5):309-12. PubMed ID: 16999720
    [Abstract] [Full Text] [Related]

  • 5. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [Abstract] [Full Text] [Related]

  • 6. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U, Erhardtsen E.
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [Abstract] [Full Text] [Related]

  • 7. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F, Castillo JG, Rahmanian PB, Scurlock C, Fischer G, Adams DH.
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [Abstract] [Full Text] [Related]

  • 8. Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
    Parameswaran R, Shapiro AD, Gill JC, Kessler CM, HTRS Registry Investigators.
    Haemophilia; 2005 Mar; 11(2):100-6. PubMed ID: 15810910
    [Abstract] [Full Text] [Related]

  • 9. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
    Mayo A, Misgav M, Kluger Y, Geenberg R, Pauzner D, Klausner J, Ben-Tal O.
    Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
    [Abstract] [Full Text] [Related]

  • 10. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y, Erez E, Vidne B, Birk E, Katz J, Tamari H, Dagan O.
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [Abstract] [Full Text] [Related]

  • 11. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B, Wiis J.
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [Abstract] [Full Text] [Related]

  • 12. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass.
    Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.
    Paediatr Anaesth; 2009 Apr; 19(4):364-70. PubMed ID: 19143947
    [Abstract] [Full Text] [Related]

  • 13. Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high-responding inhibitors.
    Smith OP.
    Pathophysiol Haemost Thromb; 2002 Apr; 32 Suppl 1():22-5. PubMed ID: 12214142
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of recombinant activated factor VII in nonhemophilia children with severe or life-threatening bleeding: a report from the SeveNBleeP registry.
    Blatný J, Mathew P, Monagle P, Ovesna P, Fiamoli V.
    Blood Coagul Fibrinolysis; 2014 Jun; 25(4):326-32. PubMed ID: 24389586
    [Abstract] [Full Text] [Related]

  • 15. The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy.
    Chuansumrit A, Nuntnarumit P, Okascharoen C, Teeraratkul S, Suwansingh S, Supapannachart S.
    Pediatrics; 2002 Jul; 110(1 Pt 1):169-71. PubMed ID: 12093965
    [Abstract] [Full Text] [Related]

  • 16. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy.
    Shami VM, Caldwell SH, Hespenheide EE, Arseneau KO, Bickston SJ, Macik BG.
    Liver Transpl; 2003 Feb; 9(2):138-43. PubMed ID: 12548507
    [Abstract] [Full Text] [Related]

  • 17. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries.
    Martinowitz U, Holcomb JB, Pusateri AE, Stein M, Onaca N, Freidman M, Macaitis JM, Castel D, Hedner U, Hess JR.
    J Trauma; 2001 Apr; 50(4):721-9. PubMed ID: 11303171
    [Abstract] [Full Text] [Related]

  • 18. Recombinant activated factor VIIa use in massive transfusion and coagulopathy unresponsive to conventional therapy.
    Gowers CJ, Parr MJ.
    Anaesth Intensive Care; 2005 Apr; 33(2):196-200. PubMed ID: 15960401
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness and Safety of 4-factor Prothrombin Complex Concentrate (4PCC) in Neonates With Intractable Bleeding or Severe Coagulation Disturbances: A Retrospective Study of 37 Cases.
    Mitsiakos G, Karametou M, Gkampeta A, Karali C, Papathanasiou AE, Papacharalambous E, Babacheva E, Papadakis E, Yupsani A, Chatziioannidis I, Soubasi V.
    J Pediatr Hematol Oncol; 2019 Apr; 41(3):e135-e140. PubMed ID: 30601403
    [Abstract] [Full Text] [Related]

  • 20. Recombinant factor VIIa in preterm neonates with prolonged prothrombin time.
    Greisen G, Andreasen RB.
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):117-20. PubMed ID: 12544740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.